View Older Stories View More Recent Stories

Dec 18, 2019 06:00AM Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
Dec 9, 2019 08:00AM Nkarta Therapeutics Expands Senior Management Team with Key Hires in Finance and Clinical Development
Dec 5, 2019 08:17AM Black Diamond Therapeutics Closes $85 Million Series C Financing
Dec 4, 2019 08:00AM Civetta Therapeutics Announces $53 million Series A to Advance Lead Programs and Develop Proprietary Platform Targeting Propeller Proteins
Nov 27, 2019 09:00AM Quartet and Cambia Health Solutions Regional Health Plans Team up to Bring Improved Access to Mental Health Care Across the Pacific Northwest
Nov 18, 2019 05:16PM Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
Nov 18, 2019 07:30AM Frequency Therapeutics Provides Business Updates and Reports Third Quarter 2019 Financial Results
Nov 14, 2019 04:06PM Form 13F-HR DEERFIELD MANAGEMENT For: Sep 30
Nov 13, 2019 06:34PM Form 4 AdaptHealth Corp. For: Nov 08 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Nov 11, 2019 11:05AM Chemical & Engineering News Names Frontier Medicines One of its 10 Chemistry Start-Ups to Watch
Nov 8, 2019 04:30PM DFB Healthcare Acquisitions Corp. Announces Closing of Business Combination With AdaptHealth Holdings LLC
Nov 7, 2019 01:05PM DFB Healthcare Acquisitions Corp. Announces Stockholder Approval of Business Combination With AdaptHealth Holdings, LLC
Nov 4, 2019 08:03AM Dracen Pharmaceuticals announces DRP-104 presentations at the 2019 Society of Immunotherapy of Cancer (SITC) Meeting
Oct 17, 2019 10:58AM Donald A. Deieso, Ph.D., WCG (WIRB-Copernicus Group), Lewis C. Cantley, Ph.D., Weill Cornell Medicine & NewYork-Presbyterian Hospital, And Vanessa Bayer, Actress, Writer And Comedian, To Be Honore
Oct 15, 2019 05:20PM DFB Healthcare Acquisitions Corp. and AdaptHealth Holdings LLC Announce Amendments to Merger and Subscription Agreements
Oct 10, 2019 05:20PM DFB Healthcare Acquisitions Corp. Announces Record Date for Special Meeting of Shareholders
Oct 7, 2019 04:45PM SHINE closes $50-million financing with Oaktree to support execution of construction and commercialization plans
Sep 30, 2019 04:37PM NewLink Genetics (NLNK) and Lumos Pharma Enter Merger Agreement
Sep 30, 2019 04:35PM NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
Sep 30, 2019 04:35PM NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
Sep 26, 2019 04:19PM MATTER to Open in New York City as Part of New Life Sciences Campus
Sep 26, 2019 11:15AM Deerfield Management Brings Together Scientists, Entrepreneurs and Leading Companies to Form the New York-Based Healthcare Innovation Campus
Sep 26, 2019 09:08AM NYCEDC and Deerfield Management Partner to Create a Life Sciences Campus -- MATTER to Create LifeSci NYC's Newest Incubator
Sep 23, 2019 09:00AM Nkarta Therapeutics Named as a “Fierce 15” Biotechnology Company of 2019
Sep 23, 2019 09:00AM FierceBiotech names Frontier Medicines one of its "Fierce 15" biotech companies of 2019
Sep 18, 2019 08:00AM Nkarta Therapeutics Promotes Nadir Mahmood, Ph.D., to Chief Business Officer
Sep 17, 2019 09:00AM Edgewise Therapeutics Closes $50 Million Series B Financing
Sep 10, 2019 08:00AM Nkarta Therapeutics Appoints Vice President of Regulatory Affairs
Sep 4, 2019 08:05AM KemPharm (KMPH) Enters Definitive Collaboration and License Agreement for its ADHD Candidates with Affiliate of Gurnet Point Capital
Sep 4, 2019 08:00AM KemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point Capital
Sep 4, 2019 08:00AM Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials
Aug 21, 2019 07:00AM Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors
Aug 20, 2019 09:00AM Graybug Vision Secures $80 million of Additional Funding to Advance its Potentially Transformative Retina and Glaucoma Clinical Programs
Aug 14, 2019 04:12PM Form 13F-HR DEERFIELD MANAGEMENT For: Jun 30
Aug 14, 2019 07:30AM Nuvo Pharmaceuticals™ Announces 2019 Second Quarter Results
Jul 31, 2019 09:05AM Frontier Medicines Announces Three Executive Hires: Chief Scientific Officer, Chief Technology Officer & Head of Degrader Technologies
Jul 30, 2019 10:50AM Nuvo Pharmaceuticals™ Provides VIMOVO Patent Update
Jul 23, 2019 07:00AM Frequency Therapeutics Completes $62 Million Series C Financing
Jul 10, 2019 11:25AM Acutus Medical Announces Addition of Scott Huennekens as Executive Chairman of the Board
Jul 9, 2019 07:30AM REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers
Jul 8, 2019 08:00AM AdaptHealth to Become a Public Company via Business Combination With DFB Healthcare
Jun 26, 2019 07:30AM Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting and Updates to the Facility Agreement with Deerfield
Jun 25, 2019 09:00AM Frontier Medicines launches with $67 million to develop novel medicines that drug the "undruggable" targets driving human disease
Jun 20, 2019 11:12AM Acutus Medical Announces $170 Million in Financing
Jun 17, 2019 08:00AM Nuvo Pharmaceuticals™ Provides Corporate Update
Jun 5, 2019 08:00AM Columbia University and Deerfield Management Launch Hudson Heights Innovations
May 23, 2019 10:24AM Duchenne Muscular Dystrophy Prevalence Increases, While Incidence Remains Steady
May 19, 2019 07:00AM Schrödinger Announces Close of Latest Financing, Raising Total of $110 Million
May 15, 2019 04:52PM Form 13F-HR DEERFIELD MANAGEMENT For: Mar 31
May 14, 2019 07:00AM Nuvo Pharmaceuticals™ Announces 2019 First Quarter Results
View More Recent Stories View Older Stories